Astellas Pharma Inc (ALPMF) Annual Income Statement ()
ALPMF Quarterly Financials ()
Frequently Asked Questions About Astellas Pharma Inc (ALPMF) Stock
Astellas Pharma Inc's (ALPMF) last reported annual revenue was USD 1,603.67 Billion.
Astellas Pharma Inc's (ALPMF) annual revenue growth rate based on the revenue reported in the past 5 years is : 4.19%
Astellas Pharma Inc's(ALPMF) is profitable as of its last reported annual financials.
The net profit margin for Astellas Pharma Inc's(ALPMF) from its laster reported year is 1.06%
The return on equity (ROE) for Astellas Pharma Inc's(ALPMF) from its last reported annual financials is : 1.10%
The return on assets (ROA) for Astellas Pharma Inc's(ALPMF) from its last reported annual financials is : 1.80%
The return on invested capital (ROIC) for Astellas Pharma Inc's(ALPMF) from its last reported annual financials is : 10.96%
The Debt to Equity ratio for Astellas Pharma Inc's(ALPMF) from its last reported annual financials is : 0.00%
The dividend yield for Astellas Pharma Inc's(ALPMF) from its laster reported year is 5.00%
Astellas Pharma Inc's(ALPMF) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ALPMF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
